Pulsenmore announced today that it received FDA de novo clearance for its home-use prenatal ultrasound platform.

To help make ultrasound easier to use for every clinician, Clarius OB AI fetal biometric measurement tool automatically estimates fetal age, weight and growth intervals during a prenatal exam with a ...

"Pulsenmore stock up as at-home ultrasound secures FDA de novo authorisation" was originally created and published by Medical ...

VANCOUVER, BC, June 25, 2024 /PRNewswire/ -- Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, has obtained FDA clearance for the Clarius OB AI fetal biometric ...

Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization for the Pulsenmore ES ...

A study published in New England Journal of Medicine in late March found that when coupled with AI, Butterfly Network’s hand held ultrasound device – Butterfly iQ – can help midwives determine fetal ...

DUBLIN, Jan. 10, 2020 /PRNewswire/ -- The "Global OB-GYN Ultrasound Systems Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. The global OB-GYN ultrasound systems market is ...

The first Inteleos Africa executive is Steven Opondo, the new Director of Partnerships and Growth. "Kenya is pioneering approaches that will help transform healthcare outcomes regionally,” said Mr.

This article analyzes the moral relevance of technological artifacts and its possible role in ethical theory, by taking the postphenomenological approach that has developed around the work of Don Ihde ...